Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia
NCT ID: NCT02678585
Last Updated: 2018-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
106 participants
INTERVENTIONAL
2015-12-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nalbuphine as an Adjuvant to Local Anaesthetic Mixture in Peribulbar Cataract Surgery
NCT03436836
Nalbuphine, Fentanyl and no Additive to Local Anaesthetic Mixture
NCT03824665
Effect of Caudal Nalbuphine on Postoperative Analgesia in Children
NCT02618876
Nalbuphine Versus Fentanyl As Additives To Bupivacaine In Spinal Anaesthesia For Internal FixationI Of Tibia
NCT03535792
The Analgesic Efficacy of Perineural Nalbuphine as an Adjuvant to Bupivacaine in Ultrasound Guided Superficial Cervical Plexus Nerve Block for Thyroid Surgeries. A Double Blinded Randomized Controlled Trial.
NCT06633068
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nalbuphine
53 patients received intravenous regional lidocaine plus Nalbuphine
Nalbuphine
53 patients received intravenous regional lidocaine plus nalbuphine
Control group
53 patients received intravenous regional lidocaine
Lidocaine
53 patients received intravenous regional lidocaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nalbuphine
53 patients received intravenous regional lidocaine plus nalbuphine
Lidocaine
53 patients received intravenous regional lidocaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) physical status I-II
* age between 20 and 50 years old
* scheduled for elective unilateral short hand surgery
Exclusion Criteria
* body mass index \> 35 kg/m2
* patients with sickle cell disease or Reynaud disease
* patient refusal
20 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Bakri
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000087161
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.